JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 23, 2004; DOI: 10.1124/jpet.103.060319


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.060319v1
309/2/484    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crosson, C. E.
Right arrow Articles by Husain, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crosson, C. E.
Right arrow Articles by Husain, S.


Received for publication September 19, 2003.
Revised December 31, 2003.
Accepted for publication January 16, 2004.

Evidence for Multiple P2Y Receptors in Trabecular Meshwork Cells

Craig E. Crosson 1*, Phillip W. Yates 1, Aruna N. Bhat 1, Yurii V. Mukhin 1, Shahid Husain 1

1 Medical University of South Carolina

* Address correspondence to: E-mail: crossonc{at}musc.edu

Abstract

The purpose of this study was to determine if functional purinergic P2 receptors are present in trabecular meshwork cells. The human trabecular cell line (HTM-3) and cultured bovine trabecular cells were used to assess the effects of P2 agonists on intracellular Ca2+ levels, extracellular signal-regulated kinase (ERK1/2) activation, and P2Y receptor expression. ATP, UTP, ADP and 2-methyl-thio-adenosine triphosphate (2-MeS-ATP) each produced a concentration-dependent increase in intracellular Ca2+ in bovine trabecular cells and the HTM-3 cell line. The addition of UDP did not produce any detectable rise in intracellular Ca2+. Pretreatment with the P2Y1 receptor antagonist, MRS-2179, blocked the ADP- AND 2-MeS-ATP-induced rise in intracellular Ca2+. However, the ATP- or UTP-induced rise in intracellular Ca2+ was not inhibited by MRS-2179 pretreatment. The addition of ADP, 2-MeS-ATP, ATP or UTP were also found to activate the ERK1/2 signaling pathway. This activation of ERK1/2 was blocked by pretreatment with the MEK inhibitor, U-0126, or the PKC inhibitor, chelerythrine chloride, but not by MRS-2179. Analysis of mRNA from HTM-3 cells by RT-PCR revealed the expression of P2Y1, P2Y4, and P2Y11 receptor subtypes. These data demonstrate that multiple P2Y receptors are present in trabecular cells. Our results are consistent with the idea that the mobilization of intracellular Ca2+ results from the activation of P2Y1 and P2Y4 receptors, while the activation of the ERK1/2 pathway results from the activation of P2Y4 receptors alone. However, a role for the P2Y11 receptors in mobilization of Ca2+, or activation of the ERK1/2 pathway, cannot be discounted.


Key words: Calcium, ERK, Eye, Purinergic Receptors, Signal Tranduction, Trabecular Meshwork


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. Soto, J. Pintor, A. Peral, A. Gual, and X. Gasull
Effects of Dinucleoside Polyphosphates on Trabecular Meshwork Cells and Aqueous Humor Outflow Facility
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1042 - 1051.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.